Total Payments
$3,271
2024 Payments
$313.22
Companies
30
Transactions
141
Medicare Patients
9,390
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$3,087 (94.4%)
Education$184.09 (5.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,087 | 136 | 94.4% |
| Education | $184.09 | 5 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $457.16 | 17 | $0 (2020) |
| GlaxoSmithKline, LLC. | $381.40 | 30 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $327.66 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $210.45 | 2 | $0 (2024) |
| Ethicon Inc. | $202.56 | 2 | $0 (2024) |
| Inari Medical, Inc. | $190.84 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $169.26 | 11 | $0 (2019) |
| Gilead Sciences, Inc. | $147.79 | 9 | $0 (2022) |
| Mirati Therapeutics, Inc. | $122.49 | 1 | $0 (2023) |
| Shire North American Group Inc | $107.29 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $313.22 | 5 | Regeneron Healthcare Solutions, Inc. ($135.00) |
| 2023 | $490.22 | 6 | Inari Medical, Inc. ($190.84) |
| 2022 | $399.28 | 15 | AstraZeneca Pharmaceuticals LP ($129.67) |
| 2021 | $39.01 | 3 | Gilead Sciences, Inc. ($14.53) |
| 2020 | $173.16 | 10 | GlaxoSmithKline, LLC. ($28.46) |
| 2019 | $673.19 | 33 | Genentech USA, Inc. ($242.96) |
| 2018 | $592.14 | 36 | AstraZeneca Pharmaceuticals LP ($134.65) |
| 2017 | $590.54 | 33 | GlaxoSmithKline, LLC. ($139.86) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: PULMONOLOGY | ||||||
| 11/19/2024 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $119.15 | General |
| Category: Endo-Mechanical | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Respiratory | ||||||
| 04/06/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Airway Clearance Device | ||||||
| 12/13/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $190.84 | General |
| Category: VTE | ||||||
| 07/21/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $122.49 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: PAH | ||||||
| 04/17/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $75.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/06/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $54.99 | General |
| Category: Immunology | ||||||
| 12/09/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.77 | General |
| 10/10/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PAH | ||||||
| 09/29/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.17 | General |
| 09/28/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.52 | General |
| 08/26/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.10 | General |
| 08/24/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $83.41 | General |
| Category: Endo-Mechanical | ||||||
| 08/08/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: PAH | ||||||
| 06/26/2022 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Pulmonology | ||||||
| 06/13/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 05/13/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.01 | General |
| 04/13/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/04/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 04/04/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/25/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.93 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,468 | 3,984 | $620,585 | $321,378 |
| 2022 | 13 | 2,314 | 3,752 | $619,370 | $319,745 |
| 2021 | 15 | 2,205 | 4,109 | $722,870 | $370,472 |
| 2020 | 16 | 2,403 | 3,935 | $550,370 | $298,771 |
Total Patients
9,390
Total Services
15,780
Medicare Billing
$1.3M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 577 | 1,383 | $222,566 | $127,337 | 57.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 298 | 660 | $102,538 | $60,646 | 59.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 293 | 315 | $94,982 | $42,167 | 44.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 282 | 510 | $54,983 | $31,052 | 56.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 35 | 116 | $48,167 | $19,101 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 107 | 107 | $26,046 | $12,830 | 49.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 169 | 172 | $14,261 | $7,216 | 50.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 168 | 171 | $13,485 | $6,705 | 49.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 169 | 172 | $11,058 | $5,596 | 50.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 168 | 171 | $14,901 | $4,693 | 31.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 33 | 35 | $13,136 | $2,883 | 21.9% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 169 | 172 | $4,463 | $1,152 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 561 | 1,291 | $207,761 | $122,175 | 58.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 285 | 680 | $105,645 | $53,696 | 50.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 242 | 258 | $77,795 | $39,378 | 50.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 59 | 150 | $62,285 | $25,388 | 40.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 254 | 443 | $47,760 | $24,277 | 50.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 152 | 152 | $37,000 | $18,508 | 50.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 24 | 26 | $23,353 | $11,773 | 50.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 148 | 151 | $12,519 | $6,727 | 53.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 148 | 151 | $11,908 | $6,162 | 51.8% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 148 | 151 | $9,708 | $5,078 | 52.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 148 | 151 | $13,158 | $4,374 | 33.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 19 | 19 | $7,131 | $1,106 | 15.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 126 | 129 | $3,348 | $1,102 | 32.9% |
About Dr. Dashant Kavathia, MD
Dr. Dashant Kavathia, MD is a Pulmonary Disease healthcare provider based in Mesa, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427269638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dashant Kavathia, MD has received a total of $3,271 in payments from pharmaceutical and medical device companies, with $313.22 received in 2024. These payments were reported across 141 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,087).
As a Medicare-enrolled provider, Kavathia has provided services to 9,390 Medicare beneficiaries, totaling 15,780 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Mesa, AZ
- Active Since 05/28/2007
- Last Updated 12/05/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1427269638
Products in Payments
- Esbriet (Biological) $422.00
- Monarch Platform (Device) $202.56
- FLOWTRIEVER CATHETER, S (Device) $190.84
- TEZSPIRE (Biological) $137.05
- LIBTAYO (Biological) $135.00
- DUPIXENT (Biological) $130.44
- ANORO (Drug) $130.10
- KRAZATI (Drug) $122.49
- NUCALA (Biological) $116.92
- GLASSIA (Biological) $107.29
- ZERBAXA (Drug) $99.23
- FASENRA (Drug) $97.47
- SYMBICORT (Drug) $66.93
- TRELEGY ELLIPTA (Drug) $64.97
- LONHALA MAGNAIR (Drug) $64.13
- BROVANA (Drug) $61.71
- TYVASO (Drug) $60.42
- STIOLTO (Drug) $54.67
- CHANTIX (Drug) $53.95
- Yupelri (Drug) $51.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Mesa
Dr. George Parides, Do, DO
Pulmonary Disease — Payments: $1.0M
Pulmonary Disease $1.0M
Dr. Steven Farber, Do, DO
Pulmonary Disease — Payments: $21,369
Pulmonary Disease $21,369
Dr. Robert Groves, M.d, M.D
Pulmonary Disease — Payments: $4,541
Pulmonary Disease $4,541
G Sulit, Md, MD
Pulmonary Disease — Payments: $4,060
Pulmonary Disease $4,060
Alhassan Badahman, M.d, M.D
Pulmonary Disease — Payments: $3,937
Pulmonary Disease $3,937
Seyed Javadpoor, Md, MD
Pulmonary Disease — Payments: $3,044
Pulmonary Disease $3,044